A study investigating correlations between tumor-infiltrating lymphocytes and circulating lymphocyte subpopulations in patients with metastatic renal cell carcinoma treated with nivolumab
Latest Information Update: 25 Mar 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics; Therapeutic Use
- 25 Mar 2017 New trial record
- 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium